We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

51 hedge funds and large institutions have $258M invested in Loxo Oncology, Inc in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

2% more funds holding

Funds holding: 5051 (+1)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less capital invested

Capital invested by funds: $260M → $258M (-$2.47M)

18% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 17

Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
6
Increased
14
Reduced
17
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
-$2.99M -166,000 Closed
Alyeska Investment Group
52
Alyeska Investment Group
Illinois
-$1.43M -79,545 Closed
Millennium Management
53
Millennium Management
New York
-$847K -47,000 Closed
BJ
54
BlackRock Japan
Japan
-$17K -918 Closed
Citigroup
55
Citigroup
New York
-$4.09K -209 -100%

LOXO Hedge Fund Activity: Q3 2015 in Review

51 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2015, worth a combined $258M — down 0.95% from $260M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new LOXO positions and 4 closed out — a net gain of 2 holders — while 14 added to existing stakes and 17 trimmed.

The largest buyer was RS Investment Management, adding an estimated $6.98M. The largest seller was Deerfield Management, cutting an estimated $7.08M.

  • 51 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2015, up from 50 in Q2 2015.
  • Funds reported $258M of Loxo Oncology, Inc stock for Q3 2015, down 0.95% quarter-over-quarter.
  • 6 funds opened new Loxo Oncology, Inc positions in Q3 2015 and 4 closed out, a net change of +2 holders.
  • The largest Loxo Oncology, Inc buyer in Q3 2015 was RS Investment Management, an estimated $6.98M added.
  • The largest Loxo Oncology, Inc seller in Q3 2015 was Deerfield Management, an estimated $7.08M sold.

Based on aggregated 13F filings for Q3 2015.